|
Galcanezumab Clinical Trials
2 actively recruiting trials
No change since May 2026
Also known as: Emgality, Emgality®
Pipeline
Early 1: 1
Top Sponsors
- Xuanwu Hospital, Beijing1
- Medical University of Vienna1
Indications
- Episodic Migraine1
- Alzheimer's Disease1
- Chronic Migraine1
- Depression1
- Anxiety1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.